IRIS
SANTAMATO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.337
NA - Nord America 4.229
AS - Asia 3.489
SA - Sud America 468
AF - Africa 90
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 19
Totale 12.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.153
CN - Cina 1.270
IE - Irlanda 1.218
SG - Singapore 1.071
UA - Ucraina 829
SE - Svezia 495
FR - Francia 428
RU - Federazione Russa 394
BR - Brasile 379
HK - Hong Kong 335
IT - Italia 334
IN - India 210
TR - Turchia 184
DE - Germania 149
GB - Regno Unito 147
FI - Finlandia 146
VN - Vietnam 140
PK - Pakistan 61
CA - Canada 42
JP - Giappone 42
PL - Polonia 41
EG - Egitto 37
AR - Argentina 33
NL - Olanda 28
IR - Iran 26
MX - Messico 25
BE - Belgio 24
AU - Australia 23
CZ - Repubblica Ceca 23
BD - Bangladesh 20
ES - Italia 17
EU - Europa 17
ZA - Sudafrica 17
ID - Indonesia 15
MY - Malesia 14
TH - Thailandia 14
EC - Ecuador 12
IQ - Iraq 12
CO - Colombia 11
TW - Taiwan 11
GR - Grecia 10
SA - Arabia Saudita 10
CL - Cile 9
LY - Libia 9
RO - Romania 9
VE - Venezuela 9
AT - Austria 6
CH - Svizzera 6
KE - Kenya 6
KZ - Kazakistan 6
PE - Perù 6
JO - Giordania 5
LT - Lituania 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SI - Slovenia 5
TN - Tunisia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
NP - Nepal 4
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
HU - Ungheria 3
IL - Israele 3
MA - Marocco 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JM - Giamaica 2
KR - Corea 2
MD - Moldavia 2
MM - Myanmar 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
SM - San Marino 2
TL - Timor Orientale 2
UY - Uruguay 2
YE - Yemen 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LK - Sri Lanka 1
MC - Monaco 1
MN - Mongolia 1
MR - Mauritania 1
Totale 12.652
Salva come PNG Salva come JPEG
Città #
Dublin 1.217
Jacksonville 579
Singapore 490
Dearborn 430
Chandler 391
Nyköping 339
Hong Kong 322
Ashburn 315
Nanjing 276
Beijing 251
Santa Clara 171
Wilmington 169
Princeton 135
New York 131
Nanchang 119
Dallas 100
San Mateo 94
Ann Arbor 82
Moscow 69
Los Angeles 57
Shenyang 56
The Dalles 55
Ho Chi Minh City 52
Boardman 47
Helsinki 47
Hebei 44
Kunming 42
Tianjin 42
Des Moines 41
Seattle 38
Munich 33
Woodbridge 33
Guangzhou 32
Jiaxing 31
Bari 29
Jinan 29
Hanoi 28
Changsha 27
Ningbo 27
São Paulo 27
Hangzhou 25
Foggia 24
Pune 24
San Francisco 22
Zhengzhou 22
Milan 21
Shanghai 21
Brussels 19
Hilden 17
London 17
Belo Horizonte 16
Rome 16
Warsaw 15
Houston 14
Boston 13
Brno 13
Kraków 13
Lanzhou 13
Ankara 12
Flushing 12
Paris 12
Redwood City 12
Rio de Janeiro 12
Stockholm 12
Changchun 11
Ismailia 11
Istanbul 11
Kocaeli 11
Lahore 11
Bengaluru 10
Berlin 10
Chicago 10
Council Bluffs 10
San Genesio Ed Uniti 10
Tokyo 10
Wuhan 10
Bangkok 9
Brooklyn 9
Faisalabad 9
Giza 9
Mexico City 9
Taizhou 9
Tripoli 9
Athens 8
Buenos Aires 8
Islamabad 8
Nuremberg 8
Turku 8
Chennai 7
Haiphong 7
Hefei 7
Lethbridge 7
New Orleans 7
Norwalk 7
Toronto 7
Auburn Hills 6
Birmingham 6
Biên Hòa 6
Cairo 6
Da Nang 6
Totale 7.201
Salva come PNG Salva come JPEG
Nome #
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. 462
Approccio clinico e riabilitativo alla sindrome da conflitto subacromiale 191
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review 184
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial. 142
The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. 140
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 140
Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication. 140
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. 137
Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis 137
L’attività fisica programmata nella prevenzione dei danni secondari nel bambino diabetico” 136
VALUTAZIONE BAROPODOMETRICA IN PAZIENTI CON MORBO DI PARKINSON IN FASE INIZIALE,CONFRONTO CON GRUPPO DI CONTROLLO E E SUCCESSIVA VALUTAZIONE DOPO TRATTAMENTO RIABILITATIVO 135
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. 132
Lifestyle-related factors in predementia and dementia syndromes. 131
Efficacia comparata tra laser Neodimio YAG e ultrasuoni nel trattamento della sindrome da conflitto sub acromiale 131
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 128
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 127
Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201 127
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. 124
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. 124
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. 119
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. 118
Effect of botulinum toxin type A andmodified constraint-induced movement therapy on motor function of upper limb inchildren with obstetrical brachial plexus palsy 115
Progression to dementia in probable and possible mild cognitive impairment 114
Lipoproteins, vascular-related genetic factors, and human longevity. 113
Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? 113
severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica 112
Vascular risk factors, alcohol intake, and cognitive decline 112
SBOTE study: Extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial 112
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. 111
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 111
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. 110
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease 108
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 108
Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography. 106
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging 104
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab. 103
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 103
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 103
Dietary Fatty acids, age-related cognitive decline, and mild cognitive impairment 103
Lifestyle-related factors in predementia and dementia syndromes. 102
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 102
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature 102
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease 101
Tau aggregation inhibitors: The future of Alzheimers pharmacotherapy? 101
Current and emerging treatments for amyotrophic lateral sclerosis. 99
Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome). 99
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. 98
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity 98
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms. 97
L'ESERCIZIO ISOCINETICO 97
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 97
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults 96
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 95
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 92
Hypertension and mild cognitive impairment subtypes 91
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging 91
Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study 91
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 91
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging 89
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults. 88
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review 88
Higher total cholesterol, cognitive decline, and dementia. 87
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment 87
Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. 87
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation 87
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 87
Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms 87
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease 86
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 86
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 84
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 84
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial 83
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. 83
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? 83
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 83
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment 82
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study. 81
Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries. 80
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity 80
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 80
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 80
The role of the rehabilitation in subjects with Progressive Supranuclear Palsy: a narrative review 79
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report 78
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. 78
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? 77
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 77
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 77
Effect of intrathecal baclofen, botulinum toxin type A and arehabilitation programme on locomotor function after spinal cord injury: a casereport. 75
Pulmonary rehabilitation for patients with bronchiectasis: case reports. 75
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 75
Current epidemiological approaches to the metabolic-cognitive syndrome. 74
Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial 74
Post-stroke spasticity as a condition: a new perspective on patient evaluation 74
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 74
High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. 72
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. 71
AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study. 71
Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches 70
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 70
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 70
Totale 10.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021706 0 0 0 0 0 63 166 151 167 145 2 12
2021/2022682 100 5 32 32 39 6 17 55 99 57 46 194
2022/20233.070 245 100 88 121 104 205 89 284 1.427 99 164 144
2023/2024584 53 25 25 25 61 238 20 41 7 8 9 72
2024/20252.249 131 21 40 92 57 295 246 122 663 104 234 244
2025/20261.705 244 324 403 542 159 33 0 0 0 0 0 0
Totale 13.097